FTK FLOTEK INDUSTRIES INC/CN/
Miscellaneous Chemical Products · NYSE · SEC CIK 928054 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY59.3%
TTM net income YoY-3.1%
TTM EPS YoY-15.2%
Revenue 3-yr CAGR21.9%
Net income 3-yr CAGR105.2%
Margins
Gross margin23.3%
Operating margin13.2%
Net margin8.8%
FCF margin—
EBITDA margin14.0%
Returns
ROE24.4%
ROA11.8%
ROIC (approx.)26.2%
Asset turnover1.34x
Leverage & solvency
Liabilities / assets53.9%
Debt / equity0.00x
Current ratio2.30x
Interest coverage8.45x
Cash quality & payout
Operating cash flow / net income-0.34x
Accruals ratio15.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $237.26M | $187.03M |
| Cost of revenue | $177.43M | $147.64M |
| Gross profit | $59.83M | $39.39M |
| R&D expense | $1.82M | $1.71M |
| SG&A expense | $28.05M | $24.71M |
| Operating income | $23.24M | $12.20M |
| Interest expense | $3.94M | $1.09M |
| Pretax income | $19.66M | $11.15M |
| Income tax | -$10.87M | $649,000 |
| Net income | $30.53M | $10.50M |
| EBITDA | $25.08M | $13.09M |
| EPS (basic) | 0.90 | 0.36 |
| EPS (diluted) | 0.84 | 0.34 |
| Weighted avg. shares (diluted) | 36.16M | 30.89M |
| Balance sheet | ||
| Cash & equivalents | $5.73M | $4.40M |
| Inventory | $10.63M | $13.30M |
| Current assets | $110.78M | $96.46M |
| PP&E, net | $20.34M | $6.18M |
| Total assets | $220.05M | $170.80M |
| Current liabilities | $61.58M | $50.37M |
| Long-term debt | $40.00M | $0 |
| Total debt | $40.00M | $0 |
| Total liabilities | $106.99M | $56.90M |
| Shareholders' equity | $113.06M | $113.90M |
| Net debt | $34.27M | -$4.40M |
| Shares outstanding | 30.13M | 29.83M |
| Cash flow statement | ||
| Operating cash flow | $7.20M | $3.36M |
| Investing cash flow | -$1.98M | -$1.82M |
| Financing cash flow | -$3.74M | -$3.12M |
| Depreciation & amortization | $1.84M | $891,000 |
| Stock-based compensation | $2.30M | $1.37M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.